QUELMIA
DEAD

Serial Number

86724536

Owner

ACTAVIS, INC.

Attorney

Matthew O. Brady

Filing Date

Aug 13, 2015

Add to watchlist:

No watchlists yet
View on USPTO

QUELMIA Trademark

Serial Number: 86724536

QUELMIA is a trademark filed by ACTAVIS, INC. on August 13, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ACTAVIS, INC. (216 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 03

ALLERGAN FINANCE, LLC (37 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 16

Trademark Details

Filing Date

August 13, 2015

Registration Date

Not Registered

Published for Opposition

February 23, 2016

Goods & Services

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to sensory organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 22, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 21, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jan 18, 2019 EX4G
REVIEW OF CORRESPONDENCE COMPLETE
Jan 18, 2019 CORV
RESPONSE TO ITU OFFICE ACTION ENTERED
Oct 20, 2018 IROA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 20, 2018 EPPA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2018 TROA
ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Aug 10, 2018 INCE
SOU EXTENSION 4 FILED
Apr 13, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 13, 2018 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 3, 2018 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 7, 2017 EXRA
SOU EXTENSION 3 GRANTED
Oct 5, 2017 EX3G
SOU EXTENSION 3 FILED
Oct 5, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 5, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 30, 2017 EXRA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 29, 2017 ASGN
SOU EXTENSION 2 GRANTED
Mar 29, 2017 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 29, 2017 AITU
SOU EXTENSION 2 FILED
Mar 22, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 22, 2017 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2017 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 12, 2016 EXRA
SOU EXTENSION 1 GRANTED
Oct 10, 2016 EX1G
SOU EXTENSION 1 FILED
Oct 10, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 10, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 19, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 23, 2016 NPUB
PUBLISHED FOR OPPOSITION
Feb 23, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 3, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 2, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 2, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 2, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 2, 2015 CNEA
ASSIGNED TO EXAMINER
Nov 27, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2015 NWOS
NEW APPLICATION ENTERED
Aug 17, 2015 NWAP